PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PDAC - PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes on deadly pancreatic cancer in major trial
Disease control OngoingThis phase 3 study tests a new drug, daraxonrasib, against standard treatments for people with metastatic pancreatic cancer that has already been treated. About 500 adults with a specific RAS gene mutation will be randomly assigned to receive either the new drug or standard thera…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
Enzyme pills aim to fight weight loss in advanced pancreatic cancer
Symptom relief OngoingThis study tests whether taking pancreatic enzyme pills (pancrelipase) can help people with metastatic pancreatic cancer maintain or gain weight. The study includes 17 participants who are starting chemotherapy. Researchers will compare two different dosing schedules and measure …
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 04:34 UTC
-
New MRI technique aims to predict pancreatic cancer outcomes
Knowledge-focused TerminatedThis study explores whether a new type of MRI (6D-MRI) can predict how well treatment works in people with pancreatic cancer. Researchers will scan 36 patients before and during chemotherapy to see if the images can forecast cancer progression and surgical success. The study is c…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC